{
    "news": [
      {
        "title": "Stellar Reports Positive Research Results from KLH Glycosylation Study",
        "published": "2018-06-21 07:30:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Exercise of Warrants Resulting in Cash Proceeds of $3 Million",
        "published": "2018-05-24 15:15:00"
      },
      {
        "title": "Stellar Achieves Robust Viral Clearance for Manufacturing Process",
        "published": "2018-05-24 07:30:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Closing of $5.5 Million Public Offering",
        "published": "2018-05-15 16:05:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Pricing of $5.5 Million Public Offering",
        "published": "2018-05-11 06:00:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Second Quarter Financial Results",
        "published": "2018-05-07 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Announces One-for-Seven Reverse Split",
        "published": "2018-04-27 16:30:00"
      },
      {
        "title": "Stellar Biotech Begins Scale-Up and Expansion Project at Port Facility",
        "published": "2018-03-29 08:45:00"
      },
      {
        "title": "Stellar Biotechnologies Appoints Bioprocess Expert to Lead Manufacturing",
        "published": "2018-02-27 09:00:00"
      },
      {
        "title": "Stellar Biotechnologies Reports First Quarter 2018 Financial Results",
        "published": "2018-02-07 16:05:00"
      },
      {
        "title": "Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors",
        "published": "2018-01-25 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results",
        "published": "2017-12-01 08:00:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference",
        "published": "2017-11-29 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Third Quarter 2017 Financial Results",
        "published": "2017-08-09 16:05:00"
      },
      {
        "title": "Stellar Biotechnologies Expands Operations Team",
        "published": "2017-06-07 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at Marcum Investor Conference",
        "published": "2017-05-31 08:15:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Second Quarter 2017 Financial Results",
        "published": "2017-05-09 16:15:00"
      },
      {
        "title": "Stellar Biotechnologies and Matrivax Sign Agreement to Transfer Vaccine Technology",
        "published": "2017-03-13 16:55:00"
      },
      {
        "title": "Amaran Biotechnology Selects Stellar KLH for Cancer Vaccines",
        "published": "2017-03-01 07:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports First Quarter 2017 Financial Results",
        "published": "2017-02-06 19:15:00"
      },
      {
        "title": "Stellar Biotechnologies Congratulates Partner's Decision to Extend Drug Development for Diabetes",
        "published": "2017-02-06 07:30:00"
      },
      {
        "title": "Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region",
        "published": "2017-01-11 07:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at Biotech Showcase Conference",
        "published": "2017-01-04 07:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Fiscal Year 2016 Financial Results",
        "published": "2016-12-14 16:05:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call",
        "published": "2016-12-12 07:45:00"
      },
      {
        "title": "Stellar Biotechnologies Appoints Pharma and Capital Markets Experts to Board of Directors",
        "published": "2016-12-09 07:45:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference",
        "published": "2016-12-01 07:45:00"
      },
      {
        "title": "Stellar Board Member and Pharma Expert to Join Executive Team",
        "published": "2016-10-24 07:30:00"
      },
      {
        "title": "Stellar Appoints Investor Relations Executive to Management Team to Support Its Continuing Scale-Up",
        "published": "2016-10-05 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at International Aquaculture Symposium",
        "published": "2016-09-21 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at the 18th Rodman & Renshaw 2016 Annual Global Investment Conference",
        "published": "2016-09-06 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Third Quarter 2016 Financial Results and Operational Highlights",
        "published": "2016-08-09 08:00:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Third Quarter 2016 Corporate Update Conference Call",
        "published": "2016-08-04 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies and Neovacs Announce Formation of New Company Neostell S.A.S. in France",
        "published": "2016-07-19 08:00:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Closing of Registered Direct Offering",
        "published": "2016-07-06 12:00:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Pricing of $6.75 Million Registered Direct Offering",
        "published": "2016-06-30 08:45:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at LD Micro Invitational Conference",
        "published": "2016-06-02 08:00:00"
      },
      {
        "title": "Stellar Biotechnologies Named as a 2016 California Small Business of the Year",
        "published": "2016-05-25 09:00:00"
      },
      {
        "title": "Stellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls (CMC)",
        "published": "2016-05-23 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM)",
        "published": "2016-05-11 10:02:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Second Quarter 2016 Financial Results and Operational Highlights",
        "published": "2016-05-09 17:18:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Second Quarter 2016 Corporate Update Conference Call",
        "published": "2016-05-03 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies' Announces Effective Date of TSX-V Voluntary Delisting",
        "published": "2016-03-29 17:00:00"
      },
      {
        "title": "Stellar Biotechnologies Applies for Voluntary Delisting From TSX Venture Exchange",
        "published": "2016-03-23 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at the 28th Annual ROTH Conference",
        "published": "2016-03-09 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports First Quarter 2016 Financial Results and Operational Highlights",
        "published": "2016-02-08 16:15:00"
      },
      {
        "title": "Stellar Biotechnologies Announces First Quarter 2016 Corporate Update Conference Call",
        "published": "2016-02-04 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Presents Research on Nanofiltration Development at PepTalk Conference",
        "published": "2016-01-26 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies and Neovacs Propose to Form Joint Venture to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM)",
        "published": "2016-01-20 16:00:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at Biotech Showcase 2016 Conference",
        "published": "2016-01-08 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Fiscal Year-End 2015 Financial Results and Operational Highlights",
        "published": "2015-12-14 16:30:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Year-End 2015 Corporate Update Conference Call",
        "published": "2015-12-10 12:30:00"
      },
      {
        "title": "Stellar Biotechnologies Presents Preclinical Poster on Clostridium Difficile Research at Society for Glycobiology Meeting",
        "published": "2015-12-04 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at LD Micro Main Event",
        "published": "2015-11-24 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Commences Trading on NASDAQ",
        "published": "2015-11-05 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Approval of NASDAQ Uplisting",
        "published": "2015-11-03 16:15:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Results of Special Meeting of Shareholders",
        "published": "2015-10-29 15:04:00"
      },
      {
        "title": "Stellar Biotechnologies Issues Corporate Update",
        "published": "2015-10-23 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Participate in 6th BioMarine International Business Convention",
        "published": "2015-10-07 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies and Amaran Biotechnology Provide Update on Collaboration",
        "published": "2015-10-01 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies' Partner Neovacs Reports Potent and Long-Lasting Biological Activity of IFN-Alpha-Kinoid Immunotherapy 4 Years After Patient Dosing in Lupus Phase I/IIa Trial",
        "published": "2015-09-17 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Provides Update on Anticipated Listing on the NASDAQ Capital Market and Announces Meeting and Record Date for the Special Meeting of Shareholders on October 29, 2015",
        "published": "2015-09-15 08:30:00"
      },
      {
        "title": "CORRECTION TO STOCK SYMBOL - Stellar Biotechnologies Announces Reverse Stock Split Effective September 2, 2015",
        "published": "2015-09-02 11:30:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market",
        "published": "2015-08-28 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Third Quarter 2015 Financial Results and Operational Highlights",
        "published": "2015-08-10 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Signs Collaboration Agreement to Expand KLH Aquaculture Operations",
        "published": "2015-07-28 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Retains The Ruth Group to Advance Communications Objectives",
        "published": "2015-07-09 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at 5thAnnual LD Micro Invitational",
        "published": "2015-06-01 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at 2015 Marcum MicroCap Conference",
        "published": "2015-05-27 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies' Immunology 2015 Poster Available Online",
        "published": "2015-05-15 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Expands Online Corporate Communications Channels",
        "published": "2015-05-14 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Second Quarter 2015 Financial Results",
        "published": "2015-05-11 16:30:00"
      },
      {
        "title": "Stellar Biotechnologies Presents Poster at Immunology 2015 on the Immunogenicity of Different Forms and Preparations of KLH",
        "published": "2015-04-30 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies and Neovacs S.A. Expand KLH Supply Relationship",
        "published": "2015-04-01 02:00:00"
      },
      {
        "title": "First FDA Breakthrough Therapy Designation for KLH-Conjugate Immunotherapy Signals Key Step for Novel Carrier Molecule",
        "published": "2015-03-10 17:31:00"
      },
      {
        "title": "Stellar Biotechnologies Reports First Quarter 2015 Financial Results",
        "published": "2015-02-09 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at Biotech Showcase(TM) 2015 Conference",
        "published": "2015-01-08 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at LD Micro Conference",
        "published": "2014-11-24 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Year-End 2014 Financial Results",
        "published": "2014-11-13 10:16:00"
      },
      {
        "title": "Stellar Biotechnologies and Araclon Biotech Sign Exclusive KLH Supply Agreement for Clinical Trials in Alzheimer's Active Immunotherapies",
        "published": "2014-11-11 12:43:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Resignation of CTO Effective December 10, 2014",
        "published": "2014-11-07 13:30:00"
      },
      {
        "title": "Stellar Biotechnologies Announces Year-End 2014 Conference Call",
        "published": "2014-11-06 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies and Biovest International Sign KLH Supply Agreement for BiovaxID Immunotherapy for Follicular Non-Hodgkin's Lymphoma",
        "published": "2014-10-23 14:14:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at Rodman & Renshaw Global Investment Conference",
        "published": "2014-09-02 12:02:00"
      },
      {
        "title": "Stellar Biotechnologies Reports on Unusual Trading Activity",
        "published": "2014-08-29 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Third Quarter 2014 Financial Results and Recent Corporate Developments",
        "published": "2014-07-10 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Appoints Two Members to Scientific Advisory Board",
        "published": "2014-06-06 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Releases Corporate Video",
        "published": "2014-05-20 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at Two Upcoming Conferences",
        "published": "2014-05-15 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Retains Stonegate for Institutional Outreach",
        "published": "2014-05-07 08:30:00"
      },
      {
        "title": "Stellar Biotechnologies Launches New Corporate Website",
        "published": "2014-05-02 08:00:00"
      },
      {
        "title": "Stellar Biotechnologies Reports Second Quarter 2014 Financial Results and Recent Corporate Developments",
        "published": "2014-04-10 09:00:00"
      },
      {
        "title": "Stellar Biotechnologies to Host Corporate Update and Second Quarter 2014 Results Conference Call on April 10",
        "published": "2014-04-04 09:00:00"
      },
      {
        "title": "Stellar Biotechnologies Presenting Today at 2014 TSX Venture 50(R) Spotlight Event",
        "published": "2014-04-01 09:00:00"
      },
      {
        "title": "Stellar Biotechnologies Presents Poster on KLH Achievements at Gordon Research Conference",
        "published": "2014-03-03 09:05:00"
      },
      {
        "title": "Stellar Biotechnologies to Present at the 26th Annual ROTH Capital Growth Conference",
        "published": "2014-02-27 09:05:00"
      },
      {
        "title": "Stellar Biotechnologies Reports on Annual General and Special Meeting",
        "published": "2014-02-18 09:05:00"
      },
      {
        "title": "Stellar Biotechnologies Named 2014 TSX Venture 50(R) Company",
        "published": "2014-02-13 09:05:00"
      },
      {
        "title": "Stellar Biotechnologies Presents KLH Verification Method at Aquaculture America Conference",
        "published": "2014-02-12 09:05:00"
      },
      {
        "title": "Stellar Biotechnologies, Inc. to Present at Two Investor Conferences in January",
        "published": "2014-01-06 09:05:00"
      }
    ]
  }